Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction
NCT00145405
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Acromegaly
Interventions
DRUG:
Lanreotide Autogel and Octreotide LAR
Sponsor
Odense University Hospital